Search Results - "Lozada‐Delgado, Eunice"

RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials by Lozada-Delgado, Eunice L., Grafals-Ruiz, Nilmary, Vivas-Mejía, Pablo E.

“…Glioblastoma multiforme (GBM) is the most common and deadliest type of primary brain tumor with a prognosis of 14months after diagnosis. Current treatment for…”
Get full text

Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma by Grafals-Ruiz, Nilmary, Rios-Vicil, Christian I, Lozada-Delgado, Eunice L, Quiñones-Díaz, Blanca I, Noriega-Rivera, Ricardo A, Martínez-Zayas, Gabriel, Santana-Rivera, Yasmarie, Santiago-Sánchez, Ginette S, Valiyeva, Fatma, Vivas-Mejía, Pablo E

“…Glioblastoma (GBM) is the most common and lethal of the central nervous system (CNS) malignancies. The initiation, progression, and infiltration ability of…”
Get full text

Targeting MicroRNA-143 Leads to Inhibition of Glioblastoma Tumor Progression by Lozada-Delgado, Eunice L, Grafals-Ruiz, Nilmary, Miranda-Román, Miguel A, Santana-Rivera, Yasmarie, Valiyeva, Fatma, Rivera-Díaz, Mónica, Marcos-Martínez, María J, Vivas-Mejía, Pablo E

“…Glioblastoma (GBM) is the most common and aggressive of all brain tumors, with a median survival of only 14 months after initial diagnosis. Novel therapeutic…”
Get full text

MicroRNA-92b targets tumor suppressor gene FBXW7 in glioblastoma by Grafals-Ruiz, Nilmary, Sánchez-Álvarez, Annelis O, Santana-Rivera, Yasmarie, Lozada-Delgado, Eunice L, Rabelo-Fernandez, Robert J, Rios-Vicil, Christian I, Valiyeva, Fatima, Vivas-Mejia, Pablo E

“…Glioblastoma (GBM) is a highly aggressive and lethal primary brain tumor. Despite limited treatment options, the overall survival of GBM patients has shown…”
Get full text

Reduced expression of enolase-1 correlates with high intracellular glucose levels and increased senescence in cisplatin-resistant ovarian cancer cells by Santana-Rivera, Yasmarie, Rabelo-Fernández, Robert J, Quiñones-Díaz, Blanca I, Grafals-Ruíz, Nilmary, Santiago-Sánchez, Ginette, Lozada-Delgado, Eunice L, Echevarría-Vargas, Ileabett M, Apiz, Juan, Soto, Daniel, Rosado, Andrea, Meléndez, Loyda, Valiyeva, Fatima, Vivas-Mejía, Pablo E

Get full text

Reduced expression of enolase-1 correlates with high intracellular glucose levels and increased senescence in cisplatin-resistant ovarian cancer cells by Santana-Rivera, Yasmarie, Rabelo-Fernández, Robert J, Quiñones-Díaz, Blanca I, Grafals-Ruíz, Nilmary, Santiago-Sánchez, Ginette, Lozada-Delgado, Eunice L, Echevarría-Vargas, Ileabett M, Apiz, Juan, Soto, Daniel, Rosado, Andrea, Meléndez, Loyda, Valiyeva, Fatima, Vivas-Mejía, Pablo E

“…Despite good responses to first-line treatment with platinum-based combination chemotherapy, most ovarian cancer patients will relapse and eventually develop a…”
Get full text

The Characterization of Monoclonal Antibodies to Mouse TLT-1 Suggests That TLT-1 Plays a Role in Wound Healing by Manfredi, Barbara, Morales-Ortíz, Jessica, Díaz-Díaz, Lymarie M, Hernandez-Matias, Liz, Barreto-Vázquez, Delmaliz, Menéndez-Pérez, Javier, Rodríguez-Cordero, J Alejandro, Villalobos-Santos, Juan C, Santiago-Rivera, Edgardo, Rivera-Dompenciel, Adriana, Lozada-Delgado, Eunice L, Kuchibhotla, Madhavi, Carrasquillo-Carrión, Kelvin, Roche-Lima, Abiel, Washington, A Valance

“…Platelets play a vital role in hemostasis and inflammation. The membrane receptor TREM-like transcript-1 (TLT-1) is involved in platelet aggregation, bleeding,…”
Get more information

Abstract 527: Identification of novel target mRNAs of microRNA-143 in glioblastoma cells by Lozada-Delgado, Eunice, Valiyeva, Fatma, Marcos, Maria, Vivas, Pablo

“…Abstract The purpose of this study is to assess the biological role of microRNA-143 (miR-143) in Glioblastoma multiforme (GBM). In the United States, the…”
Get full text

Abstract 3437: Targeting microRNA-143 in glioblastoma in vivo increases tumor growth by Lozada-Delgado, Eunice, Valiyeva, Fatma, Marcos, Maria, Vivas, Pablo

“…Abstract The purpose of this study is to assess the biological role of the microRNA-143 (miR-143) in Glioblastoma multiforme (GBM). GBM is the most common and…”
Get full text

MicroRNA‐92b is a potential therapeutic target for Glioblastoma treatment by Grafals‐Ruiz, Nilmary, Lozada‐Delgado, Eunice, Santana‐Rivera, Yasmarie, Rivera‐Diaz, Monica, Valiyeva, Fatma, Vivas‐Mejía, Pablo

“…Glioblastoma is the most aggressive type of primary brain tumor with an overall survival of 14.6 months with standard care treatment (surgery, radiotherapy,…”
Get full text

Erratum: Reduced expression of enolase-1 correlates with high intracellular glucose levels and increased senescence in cisplatin-resistant ovarian cancer cells by Santana-Rivera, Yasmarie, Rabelo-Fernández, Robert J, Quiñones-Díaz, Blanca I, Grafals-Ruíz, Nilmary, Santiago-Sánchez, Ginette, Lozada-Delgado, Eunice L, Echevarría-Vargas, Ileabett M, Apiz, Juan, Soto, Daniel, Rosado, Andrea, Meléndez, Loyda, Valiyeva, Fatima, Vivas-Mejía, Pablo E

“…[This corrects the article on p. 1275 in vol. 12, PMID: 32355541.]…”
Get full text

Targeting MicroRNA-143 in Glioblastoma by Lozada Delgado, Eunice

“…Glioblastoma (GBM) is the most common and aggressive of all brain tumors, with a median survival of only 15 months after initial diagnosis. Novel therapeutic…”
Get full text